Anti-arrhythmic and cardio-protective effects of furnidipine in a rat model: A dose response study

European Journal of Pharmacology

Volumn 549, Issue 1-3, 2006, Pages 91-97

  Krzemiński, Tadeusz F ^a   Grzyb, Joanna ^a   Porc, Maurycy P ^a   Chatterjee, Shyam S ^b  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b DR WILLMAR SCHWABE GMBH AND CO KG   (Germany)

Author keywords

(Rat); Arrhythmias; Cardio protection; Furnidipine; Ischemia and re perfusion

Indexed keywords

ANTIARRHYTHMIC AGENT; CREATINE KINASE; FURNIDIPINE;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; ENZYME RELEASE; HEART ARRHYTHMIA; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HYPOTENSION; LEFT CORONARY ARTERY; MALE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; REPERFUSION INJURY; STATISTICAL SIGNIFICANCE;

ADMINISTRATION, ORAL; ANIMALS; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIA; ARRHYTHMIAS, CARDIAC; BLOOD PRESSURE; DIHYDROPYRIDINES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROCARDIOGRAPHY; HEART VENTRICLES; INJECTIONS, INTRAVENOUS; MALE; MYOCARDIAL REPERFUSION INJURY; PROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; SURVIVAL RATE;

EID: 33748957145     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.08.002     Document Type: Article

References (43)

1. Alajarin R., Alvarez-Builla J., Vaquero J.J., Sunkel C., Fau-de-Casa-Juana J., Statkov P.R., and Sanz-Aparicio J. Synthesis and chromatographic separation of the stereoisomers of furnidipine. Tetrahedron. Asymmetry 4 (1993) 617-620
2. Alajarin R., Vaquero J.J., Alvarez-Builla J., Pastor M., Sunkel C., Fau-de-Casa-Juana M., Priego J., Statkov P.R., Sanz-Aparicio J., and Fonseca I. Synthesis, structure, and pharmacological evaluation of the stereoisomers of furnidipine. J. Med. Chem. 38 (1995) 2830-2841
3. Baller D., Bretschneider H.J., and Hellige G. A critical look at currently used indirect indices of myocardial oxygen consumption. Basic Res. Cardiol. 76 (1981) 163-170
4. Bigger J.T. The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the two years after myocardial infarction. Circulation 69 (1984) 250-255
5. Braunwald E., and Kloner R.A. Myocardial reperfusion: a double-edged sword. J. Clin. Invest. 76 (1985) 1713-1719
6. Clark C., Foreman M.I., Kane K.A., McDonald F.M., and Parratt J.R. Coronary artery ligation in anesthetized rats as a method for the production of experimental dysrhythmias and for the determination of infarct size. J. Pharmacol. Methods 3 (1980) 357-368
7. Crome R., Hearse D.J., and Manning A.S. Ischemia- and reperfusion-induced arrhythmias: beneficial actions of nifedipine. J. Cardiovasc. Pharmacol. 8 (1986) 1249-1256
8. Crottogini A.J., Depaoli J.R., and Barra J.G. The effect of the new calcium antagonist nisoldipine (Bay K-5552) on myocardial infarct size limitation in conscious dogs. Am. Heart J. 110 (1985) 753-760
9. Ellrodt G., Chew C.Y.C., and Singh B.N. Therapeutic implications of slow-channel blockade in cardio-circulatory disorders. Circulation 62 (1980) 669-679
10. Faria D.B. Calcium antagonists: their effectiveness in decreasing the occurrence of ventricular fibrillation and reducing infarct size after a coronary artery occlusion. Am. J. Cardiol. 47 (1981) 15-19
11. Ferrari R., Cucchini F., Bologenesi R., Bachetti T., Boraso A., Bernocchi P., Gaia G., and Visioli D. How do calcium antagonists differ in clinical practice?. Cardiovasc. Drugs Ther. 8 (1994) 565-575
12. Furberg C.D., Psaty B.M., and Meyer J.V. Nifedipine dose-related increase in mortality in patients with coronary heart disease. Circulation 92 (1995) 1326-1331
13. Gerrhardt W. Creatine kinase. Routine UV-method. In: Bergmeyer H.U., Bergmeyer J., and Grassl M. (Eds). Methods of Enzymatic Analysis. Enzymes 1: Ocidoreductases Transferases (1983), Verlag Chemie Weinheim, Deerfield Beach, Basel 510-518 III
14. Gibbons R.J., Abrams J., Chatterjee K., Daley J., Deedwania P.C., Douglas J.S., Fergusson T.B., Fihn S.D., Fraker T.D., Gardin J.M., O'Rurke R.A., Pasternak R.C., and Williams S.V. ACC/AHA guideline update for the management of patients with chronic stable angina-summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. J. Am. Coll. Cardiol. 1 41 (2003) 159-168
15. Hamm C.W., and Opie L.H. Protection of infarcting myocardium by slow channel inhibitors. Comparative effects of verapamil, nifedipine and diltiazem on the coronary ligated isolated working rat heart. Circ. Res. 52 Suppl. I (1983) 129-138
16. Kloner R.A., Ellis S.G., Lange R., and Braunwald E. Studies of experimental coronary artery reperfusion. Effects on infarct size, myocardial function, biochemistry, ultrastructure and microvascular damage. Circulation 68 (1983) 8-15
17. Krzemiński, T., 1991. Reperfusion-induced arrhythmias in anaesthetized rats; the essential model for the study potential antidysrhythmic and cytoprotective drugs according to the Lambeth Conventions. In: Cardiovascular and Respiratory in vivo studies, (Eds.), Biomesstechnik-Verlag March GmbH, Germany, pp. 125-130.
18. Krzemiński T., Porc F., and Grzyb M. Cardioprotective effects of an oxidated metabolite of furnidipine lacking calcium antagonistic activity. Naunyn-Schmiedeberg's Arch. Pharmacol., Suppl. 2 358 (1998) R628
19. Lichtlen P.R., Hugenholtz P.G., Rafflenbeul W., Hecker H., Jost S., Nikutta P., and Deckers J.W. Retardation of coronary artery disease in man by the calcium channel blocker nifedipine. Results of INTACT (International Nifedipine Trial on Antiatherosclerotic Therapy). Cardiovasc. Drugs Ther. Suppl. 5 (1990) 1047-1068
20. Lowry O.H., Rosenbrough N.J., Farr A.L., and Randal R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193 (1957) 265-267
21. Lüscher T.F., and Yang Z. Calcium antagonists and ACE inhibitors. Effect on endothelium and vascular smooth muscle. Drugs 46 (1993) 121-132
22. Melin J.A., Becker L.C., and Hutchins G.M. Protective effect of early and late treatment with nifedipine during myocardial infarction in the conscious dog. Circulation 69 (1984) 131-141
23. Myerburg R.J. Sudden cardiac death: structure, function and time dependence of risk. Circulation 85 suppl I (1992) 2
24. Nikol S., Huehns T.Y., and Höfling B. Novel uses and potential for calcium antagonists in revascularization. Eur. Heart J. 18 (1997) 105-109
25. Opie L.H. Myocardial stunning - are calcium antagonists useful?. Cardiovasc. Drugs Ther. 8 (1994) 533-541
26. Opie L.H., Yusuf S., and Kübler W. Current status on safety and efficacy of calcium channel blockers in cardiovascular diseases: a critical analysis based on 100 studies. Prog. Cardiovasc. Dis. 43 (2000) 171-196
27. Packer M. Sudden unexpected death in patients with congestive heart failure: a second frontier. Circulation 72 (1985) 681-687
28. Pahor M., Guralnik J.M., Corti M., Foley D.J., Carbonin P., and Havlik R.J. Long-term survival and use of antihypertensive medications in older persons. J. Am. Geriat. Soc. 43 (1995) 1191-1197
29. Priori S.G., Aliot E., Blomström-Lundquist C., Bossaert L., Breithardt G., Brugda P., Camm J.J., Cappato R., Cobbe S.M., Di Mario C., Maron B.J., Mc Kenna W.J., Pedersen A.K., Ravens U., Schwartz P.J., Trusz-Gluza M., Vardas P., Wellens H.J., and Zipes D.P. Task force on sudden cardiac death, European Society of Cardiology. Summary of recommendation. Eurospace 4 (2002) 3-18
30. Ribeiro L.G.T., Brandon T.A., Debauche T.L., Maroko P.R., and Miller R.R. Anti-arrhythmic and hemodynamic effects of calcium channel blocking agents during coronary arterial reperfusion. Comparative effects of verapamil and nifedipine. Am. J. Cardiol. 48 (1981) 69-74
31. Roden D.M. Antiarrhythmic drugs: past, present and future. J. Cardiovasc. Electrophysiol. 14 (2003) 1389-1396
32. 2+ channels. Nature 303 5917 (1983) 535-537
33. Selwyn A.P., Welman E., Fox K., Horlock P., Pratt T.P., and Klein M. The effects of nifedipine on acute experimental myocardial ischemia and infarction in dogs. Circ. Res. 44 (1979) 16-23
34. Selye H., Bajusz E., Grasso S., and Mendell P. Simple techniques for the surgical occlusion of coronary vessels in the rat. Angiology 11 (1960) 398-407
35. Stack R.S., Philips III H.R., Grierson D.S., Behar V.S., Kong Y., Peter M., Swain J.L., and Greenfield J.C. Functional improvement of jeopardized myocardium following intracoronary streptokinase in acute myocardial infarction. J. Clin. Invest. 72 (1983) 84-95
36. Staessen J.A., Fagard R., Celis L.T., Arabidze G.G., and Birkenhager W.H. Randomized double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 340 (1997) 757-764
37. Statkov P., Chatterjee S.S., Straumann D., Sunkel C., Priego J., and Fau M. Furnidipine (CRE 319) a new selective and long-acting calcium entry blocking agent. Eur. J. Pharmacol. 183 4 (1990) 1320
38. Sunkel, C., Fau de Casa-Juana, M., Statkow, P., Straumann, D., 1984. 1,4-Dihydropyridines Esters and Drugs Containing These Esters. PCT int. Appl. WO 8402,132, Chem. Abstr. 101, P1911700q.
39. Thandroyen F.T. Protection against ventricular fibrillation by calcium antagonists. Am. J. Cardiol. 47 (1981) 15-18
40. Triggle D. 1,4-Dihydropyridines as calcium channel ligands and privileged structures. Cell. Mol. Neurobiol. 23 3 (2003) 293-303
41. Tumas J., Deth R., and Kloner R.A. Effects of nisoldipine, a new calcium antagonist, on myocardial infarct size and cardiac dynamics following acute myocardial infarction. J. Cardiovasc. Pharmacol. 7 (1985) 361-367
42. Vogel H.G., Vogel H.W., Schölkens B.A., Sandow J., Müller G., and Vogel F.W. Drug Discovery and Evaluation. Pharmacological Assays (2002), Springer-Verlag, Berlin 219
43. Walker M.J.A., Curtis M.J., Hearse D.J., Cambell R.W.F., Janse M.J., Yellon D.M., Cobbe S.M., Coker S.J., Harness J., Harron D.W.G., Higgins A.J., Julian D.G., Lab M.J., Manning A.S., Northover B.J., Parratt J.R., Reimersma R.A., Riva E., Russell D.C., Sheridan D.J., Winslow E., and Woodward B. The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia, infarction and reperfusion. Cardiovasc. Res. 22 (1988) 447-455